White Pine Capital LLC Supernus Pharmaceuticals, Inc. Transaction History

White Pine Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.09 - $37.88 $174,881 - $213,075	5,625 New	5,625 $200,000
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $179,275 - $222,318	-8,875 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$17.09 - $24.89 $28,625 - $41,690	-1,675 Reduced 15.88%	8,875 $211,000
Q4 2019 Feb 12, 2020	SELL	$19.93 - $29.13 $139,510 - $203,910	-7,000 Reduced 39.89%	10,550 $250,000
Q3 2019 Nov 14, 2019	SELL	$25.47 - $33.37 $85,579 - $112,123	-3,360 Reduced 16.07%	17,550 $482,000
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $18,725 - $24,293	-625 Reduced 2.9%	20,910 $692,000
Q1 2019 May 13, 2019	SELL	$32.77 - $41.99 $227,751 - $291,830	-6,950 Reduced 24.4%	21,535 $755,000
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $94,370 - $151,500	3,060 Added 12.04%	28,485 $946,000
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $19,845 - $26,932	-450 Reduced 1.74%	25,425 $1.52 Million
Q1 2018 May 14, 2018	SELL	$37.15 - $46.9 $24,147 - $30,485	-650 Reduced 2.45%	25,875 $1.19 Million
Q4 2017 Feb 13, 2018	SELL	$36.4 - $42.6 $59,696 - $69,864	-1,640 Reduced 5.82%	26,525 $1.06 Million
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $1.04 Million - $1.4 Million	28,165	28,165 $1.13 Million

279

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.01B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

Stay updated on White Pine Capital LLC with notifications on news.